# A Study Comparing Tazarotene Cream 0.1% to TAZORAC® (Tazarotene) Cream 0.1% and Both to a Placebo Control in the Treatment of Acne Vulgaris

> **NCT02886715** · PHASE3 · COMPLETED · sponsor: **Fougera Pharmaceuticals Inc.** · enrollment: 1110 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** Tazarotene Cream 0.1%
- **DRUG:** Tazorac®
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02886715
- **Lead sponsor:** Fougera Pharmaceuticals Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09-21
- **Primary completion:** 2017-05-31
- **Final completion:** 2017-05-31
- **Target enrollment:** 1110 (ACTUAL)
- **Last updated:** 2018-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02886715

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02886715, "A Study Comparing Tazarotene Cream 0.1% to TAZORAC® (Tazarotene) Cream 0.1% and Both to a Placebo Control in the Treatment of Acne Vulgaris". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02886715. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*